Pemigatinib
Pemigatinib is a potent and selective oral inhibitor of fibroblast growth factor receptors, with the highest activity against FGFR1-3. It is used in preclinical and clinical research for studying cancers driven by FGFR alterations, demonstrating efficacy in both cellular assays and animal models.
Product Specifications
CAS Number
1513857-77-6
Product Name Alternative
Cholangiocarcinoma, antineoplastic, FGFR4, FGFR3, FGFR2, FGFR1, Fibroblast growth factor receptor, FGFR, Inhibitor, inhibit, INCB054828, INCB-054828, INCB 054828, Orally, Pemigatinib
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
98.15% (May vary between batches)
Solubility
DMSO:26.58 mg/mL (54.52 mM) ;10% DMSO+90% Saline:0.1 mg/mL (0.21 mM)
Smiles
O=C (N1CC) N (C2=C (F) C=C (OC) C (OC) =C2F) CC3=C1C4=C (N=C3) NC (CN5CCOCC5) =C4
Molecular Formula
C24H27F2N5O4
Molecular Weight
487.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV664176 1.0 µg DNA
PSPH Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details